Emerging tick‐borne diseases and blood safety: summary of a public workshop

Tick‐borne agents of disease continue to emerge and subsequently expand their geographic distribution. The threat to blood safety by tick‐borne agents is ever increasing and requires constant surveillance concomitant with implementation of appropriate intervention methods. In April 2017, the Food and Drug Administration organized a public workshop on emerging tick‐borne pathogens (excluding Babesia microti and Lyme disease) designed to provide updates on the current understanding of emerging tick‐borne diseases, thereby allowing for extended discussions to determine if decisions regarding mitigation strategies need to be made proactively. Subject matter experts and other stakeholders participated in this workshop to discuss issues of biology, epidemiology, and clinical burden of tick‐borne agents, risk of transfusion‐transmission, surveillance, and considerations for decision making in implementing safety interventions. Herein, we summarize the scientific presentations, panel discussions, and considerations going forward.

[1]  A. Stassinopoulos,et al.  Inactivation of Babesia microti in red blood cells and platelet concentrates , 2017, Transfusion.

[2]  L. Tonnetti,et al.  Distribution and survival of Borrelia miyamotoi in human blood components , 2016, Transfusion.

[3]  C. Beard,et al.  County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States , 2016, Journal of Medical Entomology.

[4]  C. B. Behravesh,et al.  Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data. , 2015, The American journal of tropical medicine and hygiene.

[5]  D. Leiby,et al.  Do leukoreduction filters passively reduce the transmission risk of human granulocytic anaplasmosis? , 2015, Transfusion.

[6]  L. Kramer,et al.  Potential Role of Deer Tick Virus in Powassan Encephalitis Cases in Lyme Disease–endemic Areas of New York, USA , 2013, Emerging infectious diseases.

[7]  E. Rosenberg,et al.  Borrelia miyamotoi: A Lesson in Disease Discovery , 2013, Annals of Internal Medicine.

[8]  L. Tomsho,et al.  Metagenomic Profile of the Bacterial Communities Associated with Ixodes ricinus Ticks , 2011, PloS one.

[9]  J. P. Davis,et al.  Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. , 2011, The New England journal of medicine.

[10]  J. Cunningham,et al.  Prevalence of Ehrlichia muris in Wisconsin Deer Ticks Collected During the Mid 1990s , 2011, The open microbiology journal.

[11]  G. Ebel,et al.  Fatal case of deer tick virus encephalitis. , 2009, The New England journal of medicine.

[12]  J. Seghatchian,et al.  The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. , 2006, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[13]  L. Katz,et al.  Blood donor screening for agents of bioterror: more questions than answers , 2005, Transfusion.

[14]  P. Gubbins,et al.  Tick‐Borne Bacterial, Rickettsial, Spirochetal, and Protozoal Infectious Diseases in the United States: A Comprehensive Review , 2005, Pharmacotherapy.

[15]  R. Houghton,et al.  Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors , 2002, Transfusion.

[16]  S. Stramer,et al.  Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population , 2002, Transfusion.

[17]  J. Childs,et al.  Survival of Ehrlichia chaffeensis in refrigerated, ADSOL‐treated RBCs , 2000, Transfusion.

[18]  S. Telford,et al.  Diversity of Babesia infecting deer ticks (Ixodes dammini). , 1998, The American journal of tropical medicine and hygiene.

[19]  L. Durden,et al.  Ixodes (Ixodes) scapularis (Acari:Ixodidae): redescription of all active stages, distribution, hosts, geographical variation, and medical and veterinary importance. , 1996, Journal of medical entomology.

[20]  W. Burgdorfer,et al.  Tick-borne diseases in the United States: Rocky Mountain spotted fever and Colorado tick fever. A review. , 1977, Acta tropica.

[21]  J. Stockman.  Emergence of a New Pathogenic Ehrlichia Species, Wisconsin and Minnesota, 2009 , 2013 .

[22]  S. Telford,et al.  Risk of Lyme disease: perceptions of residents of a Lone Star tick-infested community. , 2001, Bulletin of the World Health Organization.